OVERVIEW
The global market size for particle therapy is projected to reach USD 1.452 million by 2024, increasing over the forecast period at a CAGR of 8.82%. Particle therapy market growth is primarily driven by factors such as the various benefits of particle therapy over photon therapy, increasing global cancer prevalence, increasing particle therapy acceptance in clinical trials, and increasing the number of particle therapy centers around the world.
TABLE OF CONTENT
1 Global Particle Therapy Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Particle Therapy Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Particle Therapy Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Particle Therapy Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Particle Therapy Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Particle Therapy Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Particle Therapy Market – By Type (Market Size – & million/billion)
8.1 Proton Therapy
8.2 Heavy Ion Therapy
9 Global Particle Therapy Market – By Product & Service
9.1 Products
9.2 Cyclotrons
9.3 Synchrotrons
9.4 Services
10 Global Particle Therapy Market – By System
10.1 Multi-room Systems
10.2 Single-room Systems
11 Global Particle Therapy Market – By Cancer Type
11.1 Pediatric Cancer
11.2 Breast Cancer
11.3 Lung Cancer
11.4 Head and Neck Cancer
11.5 Other
12 Global Particle Therapy Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global Particle Therapy Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global Particle Therapy Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Varian Medical Systems, Inc.
14.3 Ion Beam Applications Sa (IBA)
14.4 Mevion Medical Systems, Inc.
14.5 Provision Healthcare, LLC
14.6 Optivus Proton Therapy, Inc.
14.7 Sumitomo Heavy Industries, Ltd.
14.8 Advanced Oncotherapy PLC.
14.9 Danfysik A/S
14.10 Hitachi, Ltd.
14.11 Protom International, Inc.
14.12 Company 11 & more
15 Global Particle Therapy Market – Appendix
15.1 Sources
15.2 Abbreviations